Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. (BPTH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BPTH · as of Mar 31, 2025
Ownership Breakdown
1
Institutional Holders
▼ 21 vs Q4
$5,288
Total Inst. Value
▼ $364,827 vs Q4
9.34M
Shares Outstanding
freeFloat 99.98%
31,127
13F Shares Held
▼ 287,938 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BPTH largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
XTX TOPCO LTD pharmaceutical preparations | 31.1K | 44.08% | 44.08% | $5.29M | May 8, 2025 | NEW |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2025 | EXIT |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 14, 2025 | EXIT |
DANSKE BANK A/S pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Dec 18, 2025 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2025 | EXIT |
NATIONAL BANK OF CANADA /FI/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 12, 2025 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 9, 2025 | EXIT |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2025 | EXIT |
TWO SIGMA SECURITIES, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2025 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares21
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-20
1 new / 21 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BPTH insider trading · insider activity
Source: SEC Form 4
5
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sherwood Aline director | Jul 30, 2024 | Award | 2,000 | $1.55 | $3.1K | 2.0K | Form 4 ↗ |
Aubert Paul director | Jul 30, 2024 | Award | 2,000 | $1.55 | $3.1K | 2.0K | Form 4 ↗ |
Cleaver Heath director | Jul 30, 2024 | Award | 2,000 | $1.55 | $3.1K | 2.0K | Form 4 ↗ |
MORRIS DOUGLAS P director | Jul 30, 2024 | Award | 3,537 | $1.55 | $5.5K | 3.5K | Form 4 ↗ |
Nielsen Peter Henry President, CEO & CFO | Jul 30, 2024 | Award | 25,000 | $1.55 | $38.8K | 25.0K | Form 4 ↗ |
Cleaver Heath director | May 2, 2023 | Award | 10,000 | $1.39 | $13.9K | 10.0K | Form 4 ↗ |
Aubert Paul director | May 2, 2023 | Award | 10,000 | $1.39 | $13.9K | 10.0K | Form 4 ↗ |
Sherwood Aline director | May 2, 2023 | Award | 10,000 | $1.39 | $13.9K | 10.0K | Form 4 ↗ |
MORRIS DOUGLAS P director | May 2, 2023 | Award | 13,000 | $1.39 | $18.1K | 13.0K | Form 4 ↗ |
Nielsen Peter Henry President, CEO & CFO | May 2, 2023 | Award | 105,000 | $1.39 | $145.9K | 105.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bio-Path Holdings, Inc. (BPTH) is primarily owned by institutional investors, who hold approximately 0.3% of total shares outstanding. Company insiders own approximately 0.02%, while retail and public investors account for the remaining 99.65%.
The largest institutional shareholder of Bio-Path Holdings, Inc. is XTX TOPCO LTD, holding approximately 31,127 shares — equal to 44.08% of outstanding shares — as of March 31, 2025.
A total of 1 institutional investors currently hold BPTH stock, with a combined institutional value of approximately $5,288 as of the most recent 13F filing period.
Frequently asked questions
BPTH ownershipBio-Path Holdings, Inc. (BPTH) is primarily owned by institutional investors, who hold approximately 0.3% of shares. The largest shareholder is XTX TOPCO LTD with a 44.08% stake. Company insiders hold 0.02%. Data sourced from SEC Form 13F as of March 31, 2025.